Elimelech Okon
Overview
Explore the profile of Elimelech Okon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmon-Divon M, Meyuchas R, Shpilberg O, Okon E, Benhamida J, Yabe M, et al.
Leukemia
. 2024 Nov;
39(2):516-519.
PMID: 39516372
No abstract available.
2.
Shiloh R, Lubin R, David O, Geron I, Okon E, Hazan I, et al.
Blood
. 2023 Sep;
142(20):1740-1751.
PMID: 37738562
Histiocytoses are inflammatory myeloid neoplasms often driven by somatic activating mutations in mitogen-activated protein kinase (MAPK) cascade genes. H syndrome is an inflammatory genetic disorder caused by germ line loss-of-function...
3.
Assayag-Asherie N, Sever D, Bogdani M, Johnson P, Weiss T, Ginzberg A, et al.
PLoS One
. 2015 Dec;
10(12):e0143589.
PMID: 26624007
CD44 is a multi-functional receptor with multiple of isoforms engaged in modulation of cell trafficking and transmission of apoptotic signals. We have previously shown that injection of anti-CD44 antibody into...
4.
Davis N, Mor Y, Idelevich P, Terkieltaub D, Ziv V, Elkeles A, et al.
J Urol
. 2014 Jul;
192(6):1628-32.
PMID: 24992334
Purpose: CellDetect® is a unique platform technology comprising a proprietary plant extract and 3 dyes that enables color discrimination between malignant (red) and benign (green) cells based on specific metabolic...
5.
Idelevich P, Elkeles A, Okon E, Kristt D, Terkieltaub D, Rivkin I, et al.
Diagn Pathol
. 2010 Nov;
5:70.
PMID: 21070653
Background: A persistent goal of oncologic histochemistry is to microscopically identify neoplasia tinctorially. Consequently, the newly developed CellDetect® staining technology, that appears to exhibit this property, warrants clinical evaluation. The...
6.
Feinmesser M, Veltman V, Morgenstern S, Tobar A, Gutman H, Kaganovsky E, et al.
Am J Dermatopathol
. 2010 Jun;
32(7):665-75.
PMID: 20559114
erbB receptors contribute to tumor formation and progression. Variable expression of erbB1, erbB2, and erbB3 has been reported in nevi and melanomas; erbB4 has hardly been investigated. We examined the...
7.
Broyde A, Boycov O, Strenov Y, Okon E, Shpilberg O, Bairey O
Am J Hematol
. 2009 Apr;
84(6):338-43.
PMID: 19384938
Expression of Ki-67, a nuclear antigen protein present in all cycling cells, is used to determine the growth fraction of tumors. The aim of this study was to evaluate the...
8.
Ram R, Gafter-Gvili A, Okon E, Pazgal I, Shpilberg O, Raanani P
Acta Haematol
. 2008 Mar;
119(2):104-7.
PMID: 18367829
Gelatinous marrow transformation (GMT) is an unusual pathological manifestation of progressive malignant diseases and severe malnutrition states. GMT has been associated with various accelerated hematological malignancies, but has never been...
9.
Pazgal I, Boycov O, Shpilberg O, Okon E, Bairey O
Leuk Lymphoma
. 2007 Oct;
48(11):2213-20.
PMID: 17926187
Lymphangiogenesis-the new growth of lymphatic vessels is an important route for the metastatic spread of human cancer. The receptor tyrosine kinase VEGFR-3 is expressed predominantly on lymphatic endothelium, and activation...
10.
Ben-Dor I, Hardy B, Fuchs S, Kaganovsky E, Kadmon E, Sagie A, et al.
Cardiovasc Drugs Ther
. 2007 Oct;
21(5):339-46.
PMID: 17912622
Objective: To evaluate the potential protective affects of Epo on left ventricular (LV) function and remodeling after acute myocardial infarction (MI). Methods: Epo was injected into the peritoneum of male...